Successful Obesity Management and Counseling:

Slides:



Advertisements
Similar presentations
1 Obesity Treatment in Special Populations Smokers –All smokers, regardless of weight, should quit smoking. –Implement weight gain prevention, treatment.
Advertisements

Cardiovascular Outcomes Trials in Diabetes: The Truth, the Whole Truth, and Nothing But the Truth.
WELCOME TO SONI CLINIC.
Moderate-to-Severe Asthma Management
Overweight and Obesity: Validation as a Chronic Disease
Primary Care Challenges in Depression - To Treat or Refer?
Making the Case for Metabolic Surgery in Patients With Obesity and T2DM.
The role of metabolic surgery in the management of obesity and t2dm
Exploring the Spectrum of Excessive Daytime Sleepiness
The "Metabolically Healthy Obese"
This program will include a discussion of off-label treatment and devices and investigational agents and devices not approved by the FDA for use in the.
Does One Size Fit All in Obesity Management?
Updates on Obesity Treatment:
The Nurse View.
The Patient Journey to Remission in MDD: A Collaborative Approach
Chronic Rhinosinusitis
Charting Progress in MS Diagnosis and Treatment for Today and Tomorrow
What Comes Second?.
Can Primary Care Physicians Take the Lead in Combating Obesity?
Case Challenges in Chronic Migraine
Induction Chemotherapy for Patients With High-Risk or Secondary AML
Beyond the Basics: What You Need to Know About Treating Insomnia
Obesity Management Today:
The Resurgence of Topical Treatments Across a Spectrum of Psoriasis
Lessons Learned In Opioid Treatment From the Pain Action Consulting Team.
Integrating Epilepsy Performance Measures Into Clinical Practice
Managing Depression in Bipolar I Disorder
Current Therapy for Type II Diabetes
Precision Management of RA and Comorbidities
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
A Frontline Clinician's Guide to Managing Opioid-Induced Constipation
Team-Based Perspectives on Successful Approaches in Treating Obesity
Nontuberculous Mycobacterial Lung Disease
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Understanding PAD.
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Gene Therapy: Past, Present, and Future
Poor Response to Initial Therapy for Migraine
Updates in Neurogenic Orthostatic Hypotension
Advancing the Treatment of IBD With Biologics
When Is Biologic Therapy Appropriate for HS?
Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.
Background Study Design Materials & Methods Results Setting & Subjects
Oral Prostanoids and PAH
Navigating Treatment Options in PAH
Practical Challenges in Obesity: Is It Possible to Maintain Weight Loss?
Cancer-Associated Thrombosis
Current Issues and Emerging Advances in the Management of PKU
Lifestyle Modification for the Management of Obesity
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Patient Questions and Expert Answers in Psoriasis:
THE TRUTH ABOUT MODERN OBESITY AGENTS: ARE THEY REALLY SAFE AND EFFECTIVE?
Optimizing Joint Health in Hemophilia
Pregnancy in MS.
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Novel Concepts in the Management of RCC
REF222 Danvers Diabetes Referral (CMS)
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Program Goal. Program Goal Disclaimer Overview.
Getting PPG Under Control
Obesity Management.
AMD Therapy: Where Are We Now and Where Are We Going?
Rational Pharmacotherapy Selection for Insomnia
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
A Closer Look.
Diagnostic Criteria Migraine Without Aura
Immune Checkpoint Inhibitors in Lung Cancer
Navigating the Journey
Multimodal Approaches to Cracking the Code in Low Back Pain
Presentation transcript:

Successful Obesity Management and Counseling:

Program Goals

CMS ICD-9-CM Codes for Intensive Behavioral Therapy for Obesity

FDA-Approved Weight Loss Pharmacotherapy for Long-term Use

Factors in Choosing a Weight Loss Medication

Tailoring the Treatment Plan Choosing a Weight Loss Medication

Weight Loss Medications Stopping Criteria

Medications Known To Be Associated With Drug-Induced Weight Gain

Closing Comments

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)